Measles virus causes immunogenic cell death in human melanoma.

Measles virus causes immunogenic cell death in human melanoma.
复制标题

DOI:
10.1038/gt.2011.205
复制
发表时间:
2013-01
期刊:
影响因子:
5.1
通讯作者:
--
中科院分区:
医学3区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

溶瘤病毒(OV)是很有希望的癌症治疗方法,目前有几种正在进行随机临床试验。麻疹病毒(MV)尚未在人类黑色素瘤模型中进行测试。本研究证实了MV对人黑色素瘤的疗效。人们越来越认识到,卵巢癌治疗的一个重要组成部分是招募宿主抗肿瘤免疫反应,既有先天的,也有适应性的。MV介导的黑色素瘤细胞死亡是一个炎症过程,导致包括1型干扰素和潜在危险信号HMGB1在内的炎症细胞因子的释放。在这里,利用人类体外模型,我们证明了MV增强了天然的抗肿瘤活性,并且MV介导的黑色素瘤细胞死亡能够刺激黑色素瘤特异性适应性免疫反应。
Oncolytic viruses (OV) are promising treatments for cancer, with several currently undergoing testing in randomised clinical trials. Measles virus (MV) has not yet been tested in models of human melanoma. This study demonstrates the efficacy of MV against human melanoma. It is increasingly recognised that an essential component of therapy with OV is the recruitment of host anti-tumour immune responses, both innate and adaptive. MV-mediated melanoma cell death is an inflammatory process, causing the release of inflammatory cytokines including type-1 interferons and the potent danger signal HMGB1. Here, using human in vitro models, we demonstrate that MV enhances innate antitumour activity, and that MV-mediated melanoma cell death is capable of stimulating a melanoma-specific adaptive immune response.
HMGB1:内源性危险信号。
DOI: 10.2119/2008-00034.klune
发表时间: 2008-07
期刊: MOLECULAR MEDICINE
影响因子: 5.7
作者:
Klune, John R.;Dhupar, Rajeev;Cardinal, Jon;Billiar, Timothy R.;Tsung, Allan
通讯作者: Tsung, Allan
DOI: 10.1038/gt.2010.121
发表时间: 2011-02-01
期刊: GENE THERAPY
影响因子: 5.1
作者:
Huang, B.;Sikorski, R.;Thorne, S. H.
通讯作者: Thorne, S. H.
DOI: 10.1182/blood-2004-11-4558
发表时间: 2005-10-01
期刊: BLOOD
影响因子: 20.3
作者:
Heinzerling, L;Künzi, V;Dummer, R
通讯作者: Dummer, R
DOI: 10.1128/jvi.73.11.9568-9575.1999
发表时间: 1999-11-01
影响因子: 5.4
作者:
Duprex, WP;McQuaid, S;Rima, BK
通讯作者: Rima, BK
DOI: 10.1158/1078-0432.ccr-05-1803
发表时间: 2006-03-15
影响因子: 11.5
作者:
Hasegawa, K;Pham, L;Peng, KW
通讯作者: Peng, KW